Cardiac Rhythm Management (CRM) Devices Market Size, Share and Industry Analysis Product By (Cardiac Pacemakers, Defibrillators, Cardiac Resynchronization Therapy Devices) By End User (Hospitals & Clinics, Ambulatory Surgery Centers), and Regional Forecast, 2019 - 2026

CRM devices are extensively used to treat arrhythmia, bradycardia, tachycardia, and sudden cardiac arrests. Since the prevalence of cardiac rhythm conditions is increasing, the adoption of cardiac rhythm management devices has been increased significantly during the past decade.

Additionally, emerging nations are witnessing a huge demand for cardiac rhythm management devices due to a higher prevalence of cardiac conditions, increasing awareness about products amongst the population, and increasing per capita income. According to the European Cardiac Society, in 2017, certain countries in Western Europe were having an implant rate of more than 1000 units/million population. This higher rate of implants in developed nations represents higher adoption and patient preference for CRM devices.

Get comprehensive study about this report by, request a free sample copy

Market Segmentation

"Defibrillator is expected to register attractive compound annual growth over the forecast period"

Defibrillators are generally used to treat arrhythmia and out-of-hospital cardiac arrests. Implantable cardioverter defibrillator (ICD) is highly recommended by physicians to treat irregular heartbeat, also it delivers electric shocks with the aim to restore the heartbeat. External defibrillators are widely being installed in developed as well as emerging nations in order to deal with the increasing prevalence of out-of-hospital cardiac arrests.

Moreover, in certain countries, it is mandatory to install external defibrillators at public places with the aim to offer easy access to the cardiac patient. Defibrillators accounted for an estimated 49.0% of the share in the cardiac rhythm management devices market in 2018.

To get details on market share, speak to analyst

In terms of products, the cardiac rhythm management (CRM) devices market is categorized into cardiac pacemakers, defibrillators, and cardiac resynchronization therapy (CRT) devices. Cardiac pacemakers are further categorized into single chamber pacemakers and dual chamber pacemakers. Defibrillators are further categorized into external defibrillators and implantable defibrillators. Cardiac resynchronization therapy devices are categorized into CRT-P and CRT-D. On the basis of end users, the CRM devices market is categorized into clinics& hospitals and ASCs (Ambulatory Surgery Centers) & others.

Regional Analysis

"Higher Adoption of Cardiac Rhythm Management Devices to Cope up with Higher Prevalence of Cardiac Conditions Enables Market to Hold Considerable Share in North America"

The North America CRM devices market generated a revenue of USD 5,914.1 Mn in 2018 and is expected to dominate throughout the forecast period. Higher adoption of pacemakers and ICD implants owing to the gradual shift of patient preference towards preventive care and increasing prevalence of cardiac conditions is expected to drive the market in North America. Moreover, strict implementation of government regulations with respect to installations of external defibrillators in public places is projected to result in increased adoption of external defibrillators, which will eventually boost the CRM devices market. 

To get geographical overview of this market, request a free sample copy

Key Market Drivers 

"Medtronic and Boston Scientific Corporation to Account for More Than Half of the Market Share in Terms of Revenue"

Medtronic is a leading player in the global implantable cardioverter defibrillator market. Combined with this, Medtronic also holds a considerable share of the global pacemaker market. Medtronic is anticipated to retain its leading position in the forecast duration owing to its wide range of product offerings, availability of products across the globe and strong customer base. This company, together with Boston Scientific Corporation, currently holds over half of the CRM devices market share in terms of revenue. Other players operating in the cardiac rhythm management devices market are Cardiac Science, Physio Control, Stryker, Defibtech, LLC., CU Medical Systems Inc., Abbott, Boston Scientific Corporation, LivaNova PLC, MicroPort, BIOTRONIK, and others.

KEY COMPANIES COVERED IN THE REPORT

• Medtronic


• Boston Scientific Corporation


• Biotronik


• Asahi Kasei Corporation


• Philips Healthcare


• Defibtech, LLC.


• Cardiac Science


• Stryker


• CU Medical System Inc.


• LivaNova Plc


• Abbott


• Microport


• Other prominent players

Report Coverage

Cardiac rhythm management devices are widely used to treat heart disease and heart rhythm disorders across the globe. Implantable cardioverter defibrillators and pacemakers play a major role in managing heart rhythm. Combined with this, CRM devices perform other important functions such as bradycardia pacing, defibrillation, and anti-tachycardia pacing. Dramatically increasing prevalence of cardiac conditions and proven efficiency of cardiac rhythm management devices to treat such conditions is anticipated to offer huge potential for growth of the cardiac rhythm management devices market share by 2026.

The report provides qualitative and quantitative insights on the CRM devices industry and detailed analysis of CRM devices market size and growth rate for all possible segments in the market. The market is segmented by product, by the end user, and by region. On the basis of the product, the cardiac rhythm management devices industry is segmented into cardiac pacemakers, defibrillators, and cardiac resynchronization devices.

Cardiac pacemakers are further segmented into single chamber pacemakers and dual chamber pacemakers. Defibrillators are further segmented into external defibrillators and implantable defibrillators. Cardiac resynchronization therapy devices are categorized into CRT-P and CRT-D. Various end users covered under the report are hospitals & clinics and ambulatory surgery centers and others. Geographically, the market is segmented into four major regions, which are North America, Europe, Asia Pacific, and the rest of the World. The regions are further categorized into countries.

To get information on various segments, share your queries with us

Along with this, the report provides an elaborative analysis of the CRM devices market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of sudden cardiac arrests in key countries, technological advancements in cardiac rhythm management devices, recent industry developments such as mergers & acquisitions, the regulatory scenario in key countries, new product launches, reimbursement scenario, and key industry trends.

SEGMENTATION

Key Industry Developments

• In March 2019, Biotronik launched MRI compatible ICD and CRT-D system in Europe market.


• In November 2017, Medtronic got FDA approval for their Azure pacemakers. These newly developed pacemakers are equipped with BlueSync technology which enables device longevity and improved patient monitoring.


• In July 2017, Biotronik launched Evity cardiac resynchronization therapy pacemaker (CRT-P) in Japan market. According to company estimates, it is the highest performing CRT-P with battery life of 10 years.